RESUMO
Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.
RESUMO
The global nephrology community recognizes the need for a cohesive strategy to address the growing problem of end-stage kidney disease (ESKD). In March 2018, the International Society of Nephrology hosted a summit on integrated ESKD care, including 92 individuals from around the globe with diverse expertise and professional backgrounds. The attendees were from 41 countries, including 16 participants from 11 low- and lower-middle-income countries. The purpose was to develop a strategic plan to improve worldwide access to integrated ESKD care, by identifying and prioritizing key activities across 8 themes: (i) estimates of ESKD burden and treatment coverage, (ii) advocacy, (iii) education and training/workforce, (iv) financing/funding models, (v) ethics, (vi) dialysis, (vii) transplantation, and (viii) conservative care. Action plans with prioritized lists of goals, activities, and key deliverables, and an overarching performance framework were developed for each theme. Examples of these key deliverables include improved data availability, integration of core registry measures and analysis to inform development of health care policy; a framework for advocacy; improved and continued stakeholder engagement; improved workforce training; equitable, efficient, and cost-effective funding models; greater understanding and greater application of ethical principles in practice and policy; definition and application of standards for safe and sustainable dialysis treatment and a set of measurable quality parameters; and integration of dialysis, transplantation, and comprehensive conservative care as ESKD treatment options within the context of overall health priorities. Intended users of the action plans include clinicians, patients and their families, scientists, industry partners, government decision makers, and advocacy organizations. Implementation of this integrated and comprehensive plan is intended to improve quality and access to care and thereby reduce serious health-related suffering of adults and children affected by ESKD worldwide.
Assuntos
Países em Desenvolvimento , Planejamento em Saúde , Acessibilidade aos Serviços de Saúde , Falência Renal Crônica/terapia , Terapia de Substituição Renal/economia , Cobertura Universal do Seguro de Saúde , Tratamento Conservador , Carga Global da Doença , Saúde Global , Ocupações em Saúde/educação , Política de Saúde , Acessibilidade aos Serviços de Saúde/economia , Acessibilidade aos Serviços de Saúde/ética , Mão de Obra em Saúde , Humanos , Falência Renal Crônica/epidemiologia , Falência Renal Crônica/prevenção & controle , Defesa do Paciente , Terapia de Substituição Renal/efeitos adversos , Terapia de Substituição Renal/ética , Terapia de Substituição Renal/normas , Cobertura Universal do Seguro de Saúde/economiaRESUMO
Professional organizations, such as kidney foundations, have been active for over half a century in the field of nephrology, serving as the basic institutions for advocacy, disease education, prevention, and treatment. These organizations have focused efforts in four areas: supporting the training of clinical specialists, raising awareness about kidney disease, improving patient outcomes, and organizing continuing medical education. These activities, while essential for the success of nephrology organizations, do not usually initiate renal service programs in the neediest of places. To remedy the lack of renal programs in many developing countries, the Sustainable Kidney Care Foundation (SKCF) was founded with the objective of establishing treatment programs for acute kidney injury (AKI) in areas of the world where none exist. Today SKCF is active in 5 sub-Saharan African countries and is growing.
Assuntos
Injúria Renal Aguda/terapia , Países em Desenvolvimento , Fundações , Diálise Peritoneal/métodos , Adolescente , Adulto , África Subsaariana , Idoso , Criança , Pré-Escolar , Feminino , Fundações/organização & administração , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Nefrologia/educação , Diálise Peritoneal/instrumentação , Diálise Peritoneal/enfermagem , Desenvolvimento de Programas , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Developing sustainable treatment programs for kidney failure in most countries of sub-Saharan Africa continues to remain an imposing challenge. While long-term renal replacement therapies in end-stage renal disease appear beyond national financial capabilities, there exist opportunities for a short-term and affordable treatment of acute kidney injury (AKI). Peritoneal dialysis (PD) is an effective and simpler modality compared to hemodialysis (HD) and can be performed without the need for machinery or electricity, making it an ideal choice in a low-resource setting. METHODS: Since cost of treatment is the major obstacle, the goal is to develop a program that is cost effective. Developing an HD program requires a large capital investment by the hospital, needing water treatment systems and machinery and providing for their ongoing repair and maintenance. Gravity-driven PD is a simple, effective modality and can be performed in low-resource locales. RESULTS: In a pediatric program that we started in the Komfo Anokye Teaching Hospital in Kumasi, Ghana, 28 patients have been treated with PD for AKI so far. Half of them were treated successfully and were discharged having fully recovered kidney function. Seven patients (25%) were determined to have end-stage renal disease, whereas 7 others (25%) died during hospitalization. In these cases, late presentation for dialysis may have contributed to the inability to recover. CONCLUSION: For individuals and governments alike, who are concerned about the cost of providing or paying for dialysis, using PD to treat AKI is an effective and simpler modality compared to HD and can be performed without the need for machinery or electricity, making it an ideal choice in a low-resource setting.
Assuntos
Injúria Renal Aguda/terapia , Diálise Peritoneal , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/mortalidade , Adolescente , África Subsaariana , Criança , Pré-Escolar , Feminino , Custos de Cuidados de Saúde , Humanos , Lactente , Recém-Nascido , Masculino , Avaliação de Resultados em Cuidados de SaúdeRESUMO
The literature abounds with attestations about the lack of treatment programs for kidney injury in developing countries. To date, no sustainable treatment program exists for acute kidney injury (AKI) in many of the 48 countries in the sub-Saharan region of Africa. The Sustainable Kidney Care Foundation, together with industry, universities, and funding organizations, has been working on establishing peritoneal dialysis treatment programs for AKI in East Africa, starting with the countries comprising the East African Community and with a special focus on treating children and women of childbearing age.
Assuntos
Injúria Renal Aguda/terapia , Diálise Peritoneal/economia , Diálise Peritoneal/métodos , Injúria Renal Aguda/economia , Adulto , África , Criança , Países em Desenvolvimento/economia , Educação Médica/economia , Educação em Enfermagem/economia , Feminino , Humanos , Desenvolvimento de Programas/economiaAssuntos
Falência Renal Crônica/terapia , Diálise Renal/métodos , Doenças Cardiovasculares/complicações , Soluções para Hemodiálise/uso terapêutico , Humanos , Rim/patologia , Falência Renal Crônica/complicações , Falência Renal Crônica/economia , Falência Renal Crônica/patologia , Diálise Renal/economiaAssuntos
Diálise Renal/economia , Insuficiência Renal Crônica/economia , Insuficiência Renal Crônica/terapia , Doenças Cardiovasculares/etiologia , Humanos , Falência Renal Crônica/economia , Diálise Renal/instrumentação , Diálise Renal/métodos , Insuficiência Renal Crônica/complicações , Transtornos do Sono-Vigília/complicaçõesRESUMO
A number of denominators for scaling the dose of dialysis have been proposed as alternatives to the urea distribution volume (V). These include resting energy expenditure (REE), mass of high metabolic rate organs (HMRO), visceral mass, and body surface area. Metabolic rate is an unlikely denominator as it varies enormously among humans with different levels of activity and correlates poorly with the glomerular filtration rate. Similarly, scaling based on HMRO may not be optimal, as many organs with high metabolic rates such as spleen, brain, and heart are unlikely to generate unusually large amounts of uremic toxins. Visceral mass, in particular the liver and gut, has potential merit as a denominator for scaling; liver size is related to protein intake and the liver, along with the gut, is known to be responsible for the generation of suspected uremic toxins. Surface area is time-honored as a scaling method for glomerular filtration rate and scales similarly to liver size. How currently recommended dialysis doses might be affected by these alternative rescaling methods was modeled by applying anthropometric equations to a large group of dialysis patients who participated in the HEMO study. The data suggested that rescaling to REE would not be much different from scaling to V. Scaling to HMRO mass would mandate substantially higher dialysis doses for smaller patients of either gender. Rescaling to liver mass would require substantially more dialysis for women compared with men at all levels of body size. Rescaling to body surface area would require more dialysis for smaller patients of either gender and also more dialysis for women of any size. Of these proposed alternative rescaling measures, body surface area may be the best, because it reflects gender-based scaling of liver size and thereby the rate of generation of uremic toxins.
Assuntos
Nefropatias/metabolismo , Nefropatias/patologia , Diálise Renal , Superfície Corporal , Metabolismo Energético/fisiologia , Feminino , Humanos , Nefropatias/terapia , Testes de Função Renal , Fígado/patologia , Masculino , Tamanho do Órgão , Fatores SexuaisRESUMO
BACKGROUND: Clinical performance targets are intended to improve patient outcomes in chronic disease through quality improvement, but evidence of an association between multiple target attainment and patient outcomes in routine clinical practice is often lacking. METHODS: In a national prospective cohort study (ESRD Quality, or EQUAL), we examined whether attainment of multiple targets in 668 incident hemodialysis patients from 74 U.S. not-for-profit dialysis clinics was associated with better outcomes. We measured whether the following accepted clinical performance targets were met at 6 months after study enrollment: albumin (> or =4.0 g/dl), hemoglobin (> or =11 g/dl), calcium-phosphate product (<55 mg2/dl2), dialysis dose (Kt/V> or =1.2), and vascular access type (fistula). Outcomes included mortality, hospital admissions, hospital days, and hospital costs. RESULTS: Attainment of each of the five targets was associated individually with better outcomes; e.g., patients who attained the albumin target had decreased mortality [relative hazard (RH) = 0.55, 95% confidence interval (CI), 0.41-0.75], hospital admissions [incidence rate ratio (IRR) = 0.67, 95% CI, 0.62-0.73], hospital days (IRR = 0.61, 95% CI, 0.58-0.63), and hospital costs (average annual cost reduction = 3,282 dollars, P = 0.002), relative to those who did not. Increasing numbers of targets attained were also associated, in a graded fashion, with decreased mortality (P = 0.030), fewer hospital admissions and days (P < 0.001 for both), and lower costs (P = 0.029); these trends remained statistically significant for all outcomes after adjustment (P < 0.001), except cost, which was marginally significant (P = 0.052). CONCLUSION: Attainment of more clinical performance targets, regardless of which targets, was strongly associated with decreased mortality, hospital admissions, and resource use in hemodialysis patients.
Assuntos
Instituições de Assistência Ambulatorial/normas , Hospitalização/estatística & dados numéricos , Falência Renal Crônica/terapia , Avaliação de Resultados em Cuidados de Saúde , Garantia da Qualidade dos Cuidados de Saúde , Diálise Renal/normas , Idoso , Fosfatos de Cálcio/análise , Feminino , Objetivos , Recursos em Saúde/estatística & dados numéricos , Hemoglobinas/análise , Hospitalização/economia , Humanos , Falência Renal Crônica/diagnóstico , Falência Renal Crônica/mortalidade , Masculino , Pessoa de Meia-Idade , Organizações sem Fins Lucrativos , Guias de Prática Clínica como Assunto , Estudos Prospectivos , Indicadores de Qualidade em Assistência à Saúde , Diálise Renal/economia , Diálise Renal/mortalidade , Albumina Sérica/análise , Estados Unidos/epidemiologiaRESUMO
The cause of the increase in core temperature (CT) during hemodialysis (HD) is still under debate. It has been suggested that peripheral vasoconstriction as a result of hypovolemia, leading to a reduced dissipation of heat from the skin, is the main cause of this increase in CT. If so, then it would be expected that extracorporeal heat flow (Jex) needed to maintain a stable CT (isothermic; T-control = 0, no change in CT) is largely different between body temperature control HD combined with ultrafiltration (UF) and body temperature control HD without UF (isovolemic). Consequently, significant differences in DeltaCT would be expected between isovolemic HD and HD combined with UF at zero Jex (thermoneutral; E-control = 0, no supply or removal of thermal energy to and from the extracorporeal circulation). During the latter treatment, the CT is expected to increase. In this study, changes in thermal variables (CT and Jex), skin blood flow, energy expenditure, and cytokines (TNF-alpha, IL-1 receptor antagonist, and IL-6) were compared in 13 patients, each undergoing body temperature control (T-control = 0) HD without and with UF and energy-neutral (E-control = 0) HD without and with UF. CT increased equally during energy-neutral treatments, with (0.32 +/- 0.16 degrees C; P = 0.000) and without (0.27 +/- 0.29 degrees C; P = 0.006) UF. In body temperature control treatments, the relationship between Jex and UF tended to be significant (r = -0.51; P = 0.07); however, there was no significant difference in cooling requirements regardless of whether treatments were done without (-17.9 +/- 9.3W) or with UF (-17.8 +/- 13.27W). Changes in energy expenditure did not differ among the four treatment modes. There were no significant differences in pre- and postdialysis levels of cytokines within or between treatments. Although fluid removal has an effect on thermal variables, no single mechanism seems to be responsible for the increased heat accumulation during HD.
Assuntos
Temperatura Corporal/fisiologia , Metabolismo Energético/fisiologia , Hemodiafiltração , Pele/irrigação sanguínea , Pele/metabolismo , Feminino , Hemodinâmica , Humanos , Masculino , Fluxo Sanguíneo Regional , Diálise Renal , Temperatura Cutânea/fisiologiaAssuntos
Pressão Sanguínea , Hipertensão/etiologia , Hipertensão/terapia , Papel do Profissional de Enfermagem , Diálise Renal/métodos , Diálise Renal/normas , Velocidade do Fluxo Sanguíneo , Nitrogênio da Ureia Sanguínea , Volume Sanguíneo , Soluções para Diálise , Dieta Hipossódica , Líquido Extracelular , Hemodiafiltração , Hemodiálise no Domicílio/métodos , Hemodiálise no Domicílio/normas , Humanos , Hipertensão/fisiopatologia , Hipertensão/prevenção & controle , Medicare , Nefrologia , Papel do Médico , Diálise Renal/enfermagem , Diálise Renal/tendências , Insuficiência Renal/metabolismo , Insuficiência Renal/fisiopatologia , Insuficiência Renal/terapia , Fatores de Tempo , Estados Unidos , Recursos HumanosRESUMO
Protein-energy malnutrition is seen in patients with advanced stages of chronic kidney disease (CKD) and is even more pronounced in patients receiving long-term hemodialysis treatment. Both entities have great impact on patient morbidity and mortality. Analysis of body composition is an integral part of nutritional assessment and includes the estimation of muscle, fat, and fat-free mass, as well as the extracellular water compartment. Clinical assessment of these compartments is difficult, and gold-standard methods such as tracer dilution, magnetic resonance imaging, and dual-energy x-ray absorptiometry are expensive, cumbersome, and rarely available. We report an ongoing study of body composition in hemodialysis patients involving deuterium and sodium bromide dilution, total body potassium counting, magnetic resonance imaging, whole-body and segmental bioimpedance spectroscopy, and anthropometry. The goals of the study are (1) to validate bioimpedance technology against gold-standard methods for assessment of the various body compartments, (2) to directly quantify visceral adipose tissue mass, a potential source of cytokine production (adipokines) promoting chronic inflammation, and to study its relation to inflammatory markers, and (3) to directly quantify visceral organ mass and to study its relation to uremia toxin generation as assessed by protein catabolic rate and resting energy expenditure. Preliminary results based on up to 40 hemodialysis patients are reported.
Assuntos
Composição Corporal , Nefropatias/complicações , Desnutrição Proteico-Calórica/diagnóstico , Diálise Renal , Tecido Adiposo , Adulto , Idoso , Antropometria , Índice de Massa Corporal , Água Corporal , Brometos , Deutério , Impedância Elétrica , Feminino , Humanos , Técnicas de Diluição do Indicador , Inflamação/complicações , Gordura Intra-Abdominal , Nefropatias/terapia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Músculo Esquelético , Radioisótopos de Potássio/análise , Desnutrição Proteico-Calórica/etiologia , Compostos de Sódio , Uremia/complicaçõesRESUMO
BACKGROUND: The Dialysis Outcomes and Practice Patterns Study is well suited to identify case-mix effects, given its extensive data set. The data set was used to examine the influence of case-mix variables on mortality and the extent to which these variables account for differences in mortality across regions, as well as the prevalence and incidence of hepatitis B and hepatitis C. METHODS: Demographic and comorbid disease features were determined for 8,615 patients internationally; mortality was recorded for this cohort, plus replacement patients (total n = 16,720), from 1996 to 2002. Mortality was associated with increasing age, nonblack race, coronary artery disease, congestive heart failure, other cardiac disease, diabetes mellitus, peripheral vascular disease, cerebrovascular disease, absence of hypertension, lung disease, cancer, human immunodeficiency virus infection, gastrointestinal bleeding, neurologic disease, psychiatric disease, cellulitis/gangrene, hepatitis C, and smoking. RESULTS: US patients were slightly older than those in Europe or Japan and had the highest prevalence of diabetes, coronary artery disease, congestive heart failure, peripheral vascular disease, and cerebrovascular disease. CONCLUSION: Upon adjusting for case-mix to assess mortality across facilities, it was found that regional differences in mortality (highest in the United States and lowest in Japan) and differences across facilities within nations remain after such corrections. It is likely that practice patterns account for some of this variation. Prevalence of hepatitis B virus (HBV) across facilities increased as the number of dialyzing patients per facility increased; risk of HBV seroconversion decreased among facilities using protocols for treatment of patients with HBV infection. Greater employment of staff with at least 2 years of formal nursing training was associated with lower prevalence of hepatitis C virus infection and lower seroconversion risk.
Assuntos
Diálise Renal/mortalidade , Comorbidade , Grupos Diagnósticos Relacionados , Europa (Continente)/epidemiologia , Humanos , Japão/epidemiologia , Falência Renal Crônica/mortalidade , Falência Renal Crônica/terapia , Estados Unidos/epidemiologiaRESUMO
A new ultrasound instrument has been developed, using vector Doppler and embedded machine intelligence, to enable measurement of access flow rates by non-specialists. Ultrasound measurement of access flow can be performed with the patient off the dialysis machine, avoiding the hemodynamic changes that may affect indicator-dilution methods. A research version of the instrument was tested on flow phantoms simulating graft flow, and showed accuracy better than 5%. A non-specialist measured flow in the access grafts of 7 consenting dialysis patients; the instrument showed flows commensurate with indicator-dilution-measured flows, but with less variability. Measurements were made in less than 5 min per patient. The cost per measurement is calculated to be significantly less than that of present methods of measuring flow. The new instrument may become a useful tool for monitoring flow in accesses to extend their life.
Assuntos
Pessoal Técnico de Saúde , Velocidade do Fluxo Sanguíneo , Cateteres de Demora , Fluxômetros , Ultrassonografia Doppler Dupla/instrumentação , Pessoal Técnico de Saúde/economia , Braço/irrigação sanguínea , Braço/diagnóstico por imagem , Pressão Sanguínea , Desenho de Equipamento , Humanos , Variações Dependentes do Observador , Imagens de Fantasmas , Diálise Renal , Ultrassonografia Doppler Dupla/economiaRESUMO
Dialysis facilities face important trade-offs between cost and quality under constrained capitated reimbursement. How management at dialysis facilities makes decisions affecting cost and quality of care and views opportunities and threats is unknown. We conducted a national survey of dialysis facility administrators. We asked administrators what changes they would make in response to increases or decreases in reimbursement, their views on linking dialysis care payment to quality-of-care measures, and their views on providing patients with treatment options and outcomes information. One hundred fifty-seven of 280 dialysis facility administrators (56%) responded. If dialysis reimbursement were to increase by 20%, the five most common responses were to: improve patient education programs (62% of respondents), improve facility amenities (42%), purchase new equipment (30%), provide more money for staff salaries (28%), and increase number of nursing staff (21%). Conversely, if dialysis reimbursement were to decrease by 20%, the most common responses were to: limit staff salary (45% of respondents), decrease nursing staff (41%), not replace dialysis equipment (43%), increase dialyzer reuse (37%), and return less to investors (36%). Differences in rank order of responses were observed according to professional training of the administrator and profit status of the facility. Administrators uniformly believe that it is very acceptable to provide facility-specific outcomes data to the public, as well as information on modalities of treatment provided by facilities. However, administrators varied in their views regarding whether reimbursement should be based on quality by using a process-of-care measure, such as the average dose of dialysis, or an outcome-of-care measure, such as case-mix-adjusted mortality rates. We conclude that increases in facility reimbursement generally would be used by dialysis facility administrators for the benefit of patients, whereas decreases (or inflation erosion) in payment rates might compromise staffing. US dialysis administrators support sharing treatment options and outcomes information with patients, but appear to be ambivalent with regard to linking reimbursement to adequacy of dialysis or patient outcomes. These results have important implications regarding proposed changes in the US capitated dialysis payment rate and current efforts to empower consumers of dialysis care.